HF004
In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction who are currently treated with an ACE-I or ARB, the percentage of patients who are additionally currently treated with a beta- blocker licensed for heart failure for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF004 | 2019 | 69 | 76 | 90.8% | |
| HF004 | 2020 | 71 | 74 | 96.0% | |
| HF006 | 2021 | 100 | 103 | 97.1% | |
| HF006 | 2022 | 97 | 100 | 97.0% | |
| HF006 | 2023 | 94 | 98 | 95.9% |
